KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurora Cannabis (ACB) Cash & Equivalents (2017 - 2025)

Aurora Cannabis has reported Cash & Equivalents over the past 9 years, most recently at $40.4 million for Q4 2025.

  • Quarterly Cash & Equivalents fell 57.43% to $40.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $40.4 million through Dec 2025, down 57.43% year-over-year, with the annual reading at $96.1 million for FY2025, 4.83% down from the prior year.
  • Cash & Equivalents was $40.4 million for Q4 2025 at Aurora Cannabis, down from $69.5 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $347.8 million in Q3 2021 and troughed at $40.4 million in Q4 2025.
  • The 5-year median for Cash & Equivalents is $173.7 million (2023), against an average of $193.8 million.
  • Year-over-year, Cash & Equivalents skyrocketed 193.14% in 2021 and then crashed 57.43% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $334.4 million in 2021, then fell by 5.28% to $316.7 million in 2022, then tumbled by 45.51% to $172.6 million in 2023, then tumbled by 44.99% to $94.9 million in 2024, then crashed by 57.43% to $40.4 million in 2025.
  • Per Business Quant, the three most recent readings for ACB's Cash & Equivalents are $40.4 million (Q4 2025), $69.5 million (Q3 2025), and $101.2 million (Q2 2025).